Aeglea BioTherapeutics
the base case spy profile was conservatively compared to and morphic | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
28 of 56
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
September 2023
a conservative spy product profile was tested against and morphic as agent | Aeglea BioTherapeutics
Related slides by other companies
Nuvalent
Investor Presentation
May 2023
preliminary safety profile favorable and consistent with the highly selective sparing design of | Nuvalent
Nuvalent
Investor Presentation
August 2023
preliminary safety profile favorable and consistent with the highly selective sparing design of | Nuvalent
Nuvalent
Investor Presentation
November 2023
preliminary safety profile favorable and consistent with the highly selective sparing design of | Nuvalent
Nuvalent
Investor Presentation
October 2022
preliminary safety profile favorable and consistent with the highly selective sparing design of sore a sar | Nuvalent
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io